Shanshan Deng Selected Research

Shanshan Deng Research Topics

Disease

26	Neoplasms (Cancer) 01/2023 - 01/2012
10	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2012
6	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2015
5	COVID-19 01/2023 - 10/2022
4	Ischemic Stroke 11/2023 - 01/2021
4	Melanoma (Melanoma, Malignant) 01/2023 - 01/2020
4	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2019
3	Inflammation (Inflammations) 01/2021 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 01/2023
2	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2018
2	Infections 01/2023 - 08/2017
2	Triple Negative Breast Neoplasms 01/2022 - 01/2020
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022 - 01/2021
2	Brain Ischemia (Cerebral Ischemia) 01/2021 - 01/2021
2	Adenocarcinoma of Lung 01/2021 - 01/2021
2	Carcinogenesis 11/2020 - 11/2018
1	Type 2 Diabetes Mellitus (MODY) 05/2024
1	Vascular System Injuries 05/2024
1	Hyperplasia 05/2024
1	Carotid Stenosis (Carotid Artery Stenosis) 11/2023
1	Stroke (Strokes) 11/2023
1	Brain Injuries (Brain Injury) 11/2023
1	Central Nervous System Diseases (CNS Diseases) 01/2023
1	Virus Diseases (Viral Diseases) 01/2023
1	Hemolysis 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Breakthrough Infections 10/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Leukemia 12/2021
1	Hematologic Neoplasms (Hematological Malignancy) 12/2021
1	Blister (Bulla) 12/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Cerebral Infarction 01/2021
1	Reperfusion Injury 01/2021
1	Neuroblastoma 01/2021
1	Pancreatitis 01/2021
1	Infarction (Infarctions) 01/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2012
7	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 01/2018
6	Tubulin ModulatorsIBA 10/2022 - 01/2019
5	TubulinIBA 01/2023 - 01/2020
5	VaccinesIBA 01/2023 - 10/2022
4	Biomarkers (Surrogate Marker)IBA 01/2024 - 07/2021
4	Oxygen (Dioxygen)IBA 11/2023 - 01/2021
4	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 01/2021
4	monocyte locomotion inhibitory factorIBA 11/2023 - 01/2021
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 08/2017
4	RNA (Ribonucleic Acid)IBA 01/2023 - 11/2018
3	Colchicine FDA LinkGeneric 01/2023 - 01/2021
3	taxaneIBA 10/2022 - 01/2020
3	CytokinesIBA 01/2022 - 01/2019
2	Neuroprotective AgentsIBA 11/2023 - 01/2021
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2019
2	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 01/2022
2	Messenger RNA (mRNA)IBA 01/2023 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 11/2018
2	sabizabulinIBA 12/2020 - 01/2020
1	linarinIBA 05/2024
1	Cyclic PeptidesIBA 11/2023
1	Peptides (Polypeptides)IBA 11/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Competitive Endogenous RNAIBA 01/2023
1	Lipid NanoparticlesIBA 01/2023
1	mRNA VaccinesIBA 01/2023
1	Long Noncoding RNAIBA 01/2023
1	Catalytic DNA (Deoxyribozyme)IBA 01/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	16S Ribosomal RNAIBA 01/2023
1	130-nm albumin-bound paclitaxelIBA 10/2022
1	Vincristine (Oncovin)FDA LinkGeneric 10/2022
1	AlkaloidsIBA 01/2022
1	FlavonoidsIBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	PhenolsIBA 01/2022
1	QuinonesIBA 01/2022
1	Growth Factor ReceptorsIBA 01/2022
1	Therapeutic UsesIBA 12/2021
1	SurvivinIBA 11/2021
1	Circular RNAIBA 06/2021
1	EnzymesIBA 01/2021
1	DipeptidesIBA 01/2021
1	CarcinogensIBA 01/2021
1	Investigational DrugsIBA 01/2021
1	Cyclin-Dependent Kinase-Activating KinaseIBA 01/2021
1	ImmunosorbentsIBA 01/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	tanshinoneIBA 01/2021
1	Lipocalin-2IBA 01/2021
1	triphenyltetrazoliumIBA 01/2021

Therapy/Procedure

7	Therapeutics 01/2023 - 01/2017
4	Drug Therapy (Chemotherapy) 11/2021 - 01/2017
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 12/2015
2	Immunomodulation 10/2022 - 11/2020
1	Radiotherapy 12/2021
1	Neoadjuvant Therapy 07/2021